Imugene
Manufacturing · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Bligh House, L 12/4-6 Bligh St Se 12.01,...Phone Number
(805) 795-1131Website
www.imugene.comRevenue
$71.9 MillionStock Symbol
IMUIndustry
About Imugene
Imugene Limited is a clinical stage cell therapy company focused on developing allogeneic CAR T cell therapies for blood cancers. Their lead product, azer-cel (azercabtagene zapreleucel), is an off-the-shelf therapy targeting CD19, currently undergoing Phase 1b clinical trials for advanced B-cell malignancies. The company aims to transform cancer treatment and improve patient outcomes through innovative therapies backed by a team of international cancer experts. Imugene is positioned to be a leader in the rapidly growing global market for cancer treatments.Explore more
Imugene Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Imugene
Compare insights from companies similar to Imugene, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Imugene Tech Stack
A closer look at the technologies used by Imugene
See more technologies
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Imugene
Sign Up For FreeTo access detailed company insights
Imugene Limited is a clinical stage cell therapy company focused on developing allogeneic CAR T cell therapies for blood cancers. Their lead product, azer-cel (azercabtagene zapreleucel), is an off-the-shelf therapy targeting CD19, currently undergoing Phase 1b clinical trials for advanced B-cell malignancies. The company aims to transform cancer t... Read More
